Ambu A/S

TRANSACTIONS UNDER AMBU'S SHARE BUYBACK PROGRAM

22.12.2025 09:43:33 CET | Ambu A/S | Changes in company's own shares

On 10 December 2025, Ambu announced a share buyback program (company announcement no. 7 2025/26). The share buyback program is carried out in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) (as amended) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, also referred to as the Safe Harbor Regulations                                                                                            

During the program, Ambu will repurchase shares for a total amount of up to DKK 150m from 10 December 2025 until no later than 31 March 2026. The repurchased shares are bought with the aim of completing a share capital decrease as set out in Article 5(2)(a) in MAR.

The following transactions have been made under the program from 15 December to 19 December 2025:

 

Number of shares

Average purchase price, DKK

Transaction value, DKK

Accumulated under the program after last announcement

150,000

85.778

12,867,960

2025.12.15

43,700

87.4031

3,819,515

2025.12.16

51,000

87.5344

4,464,254

2025.12.17

95,250

85.8411

8,176,365

2025.12.18

43,500

86.4667

3,761,301

2025.12.19

6,530

87.0998

568,762

Accumulated under the program

389,980

86.307

33,658,157

 

After the above disclosed transactions DKK 116,341,843 remains to be repurchased. Ambu now owns 3,128,815 treasury shares, corresponding to 1.2% of the share capital.

Contacts

Anders Hjort

Head of Investor Relations

anhj@ambu.com

Tine Bjørn Schmidt

Director of Corporate Communications

tisc@ambu.com

About Ambu A/S

Ever since 1937, Ambu has surpassed expectations with groundbreaking solutions that improve patient care. Millions of patients, clinicians, and health systems worldwide rely on our endoscopy, anesthesia, and patient monitoring solutions for efficiency, safety, and performance. Our ownership of every stage of the product life cycle enables us to work closely with healthcare professionals, maintain a reliable product supply, and uphold full transparency. At our headquarters in Copenhagen, Denmark, and around the world in Europe, North America, and the Asia Pacific, 5,200+ Ambu team members are committed to delivering above and beyond.

Attachments

Subscribe to our company announcements

Keep up to date with our company announcements by subscribing.

Visit our pressroom and see more company announcements from us.

Our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye